Skip to main content
Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
9.76
-1.24 (-11.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Armata Pharmaceuticals Revenue

In the year 2025, Armata Pharmaceuticals had annual revenue of $4.90M, down -5.22%. Armata Pharmaceuticals had revenue of $1.09M in the quarter ending December 31, 2025, a decrease of -12.15%.

Revenue (ttm)
$4.90M
Revenue Growth
-5.22%
P/S Ratio
72.91
Revenue / Employee
$81,733
Employees
60
Market Cap
357.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.90M-270.00K-5.22%
Dec 31, 20245.17M645.00K14.24%
Dec 31, 20234.53M-979.00K-17.77%
Dec 31, 20225.51M1.03M23.11%
Dec 31, 20214.47M3.65M443.62%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
X4 Pharmaceuticals 35.11M
Opus Genetics 14.20M
Surrozen 3.48M
Silence Therapeutics 559.00K
YD Bio 510.36K
Avalo Therapeutics 59.00K
Revenue Rankings

ARMP News

More News